Strategic Alliances for Medications Development to Treat Substance ...

The National Institutes of Health, otherwise known as NIH, is a federal government agency that?s operating within the United States Department of Health and Human Services that?s greatly accountable for all of the nation?s biomedical and health-related research studies.

The grants and programs of the NIH are all specially engineered to aid in the realization of its main agency mission which is to?seek fundamental knowledge about the nature and behavior of living systems and the application of that data to improve health, lengthen life, and scale back the burdens of sickness and disability.?

As per this mission, the National Institutes of Health, along with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies attempt to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common objective of medications development.

In addition, the National Institute on Drug Abuse (NIDA) is also meaning to request research grant applications that seek to work towards the discovery and development of efficient and safe medications for the treatment of Substance Use Disorders (SUDs), through the inception of tactical alliances and collaborations between researchers at for profit or non-profit organizations.

The organizers of the programme reckon that through the leveraging of the strengths, the pace of grant-funded medications development for SUDs will be substantially accelerated. As a result, the organizers encourage the proposals to be submitted under this program to focus at any point along the drug development continuum.

The drive is also inspired by the undeniable fact that there?s currently no FDA-approved medications for the treatment of cocaine, methamphetamine, or cannabis use disorders. To this regard, the NIH and NIDA hope that the outcome of the program will accelerate medication development, foster cooperative ventures between entities such that each offers financial resources, in-kind resources, and/or expertise towards the development of effective and safe medications for SUDs.

To support this program, the NIH and NIDA are willing to administer funds in the amount of $2,000,000 a year for a project that would last for as much as 3 years.

The institutions and organizations who will be deemed eligible to play a role in the programme are the following:

a) Higher Education Institutions such as Public and Private Institutions of Higher Education

b) Nonprofit Organizations

c) For-profit Organizations Such as Small Businesses

d) State Governments, County Governments, City or Township Governments, Special District Governments, and Indian/Native American Tribal Governments

e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Affiliations, and Faith-based or Community-based Organizations.

Source: http://angrybirdsonline.org/health-and-fitness/strategic-alliances-for-medications-development-to-treat-substance-use-disorder-program.html

marie colvin cm punk cm punk lint justin theroux buenos aires train crash pga tour